Clinical Trial

A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopathy in India.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-29
notable Trial sites reduced: 31 -> 24 locations 2026-04-29
Trial Details
NCT Number NCT07004972
Lead Sponsor Bristol-Myers Squibb
Conditions Symptomatic Obstructive Hypertrophic Cardiomyopathy
Enrollment 50 participants
Start Date 2025-09-04
Primary Completion 2027-12-13 (estimated)
Study Completion 2027-12-13 (estimated)
Updated on ClinicalTrials.gov 2026-04-28